Clinical Trials Logo

Segmentectomy clinical trials

View clinical trials related to Segmentectomy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05717803 Recruiting - Lung Adenocarcinoma Clinical Trials

Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)

Start date: February 15, 2023
Phase: Phase 3
Study type: Interventional

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1012. The goal of this clinical trial is to confirm the theraputic effect of segmentectomy for ground glass-dominant invasive lung cancer with size of 2-3cm. The main questions it aims to answer are: - The 5-year disease-free survival of patients having ground glass-dominant invasive lung cancer with size of 2-3cm; - The post-operative lung function tests after receiving segmentectomy. Participants will receive segmentectomy as the surgical procedure.

NCT ID: NCT05453721 Recruiting - Clinical trials for Non-small Cell Lung Cancer Stage I

Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane(IMPLANE-0529)

IMPLANE-0529
Start date: August 4, 2022
Phase: N/A
Study type: Interventional

This study is a multi-center, prospective, randomized controlled clinical trial. The purpose is to compare the difference of indocyanine green fluorescence imaging method and modified inflation-deflation method in identifying intersegmental plane in segmentectomy, and provide high-level evidence for the selection of intersegmental plane identification method in early NSCLC segmental resection.

NCT ID: NCT03227380 Recruiting - Segmentectomy Clinical Trials

Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy

Start date: March 31, 2017
Phase: N/A
Study type: Interventional

The objective of this study is to determine whether stapling adversely affects the pulmonary parenchyma and the vascularisation of the adjacent segments. The aim of our work is to explore by thoracic densitometry with contrast the spared segments after stapling of the intersegmental plan following a thoracoscopic segmentectomy, 3 or 6 months post-surgery. the investigator will assess venous drainage and the arterial vascularisation of the remaining segments, possible modifications of the adjacent parenchyma and whether there is a defect of pleuro-pulmonary adhesion (residual pneumothorax).